Skip to content

Effectiveness of Radiofrequency Microneedling Combined with Autologous Platelet-Rich Plasma in Postoperative Wound Healing for Patients with Facial Acne Scars: A Retrospective Study

Effectiveness of Radiofrequency Microneedling Combined with Autologous Platelet-Rich Plasma in Postoperative Wound Healing for Patients with Facial Acne Scars: A Retrospective Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120189
Enrollment
Unknown
Registered
2026-03-10
Start date
2026-03-10
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Observation Group:None
Control group:None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients who were diagnosed with acne scars in the outpatient department of dermatology in our hospital and received radiofrequency microneedling treatment for acne scars for the first time in the laser center of our hospital's dermatology department during the period from January 1, 2021 to December 31, 2023. 2.Patients who were clinically diagnosed as grade 2 or above according to the Goodman & Baron grading system before treatment, i.e., those with visible atrophic scars which can be further subdivided into three types: icepick scars (also referred to as V-shaped scars), boxcar scars (also referred to as U-shaped scars), and rolling scars (also referred to as M-shaped scars). 3.Patients aged 18 years or older, regardless of gender.

Exclusion criteria

Exclusion criteria: 1.Patients with incomplete baseline and follow-up data. 2.Patients who received retinoid therapy or other medications during the course of radiofrequency microneedling treatment. 3.Patients with facial skin conditions such as wounds, infections, herpes simplex or other herpesvirus infections during the course of radiofrequency microneedling treatment. 4.Patients who were pregnant or breastfeeding during the course of radiofrequency microneedling treatment. 5.Patients with a history of keloids. 6.Patients with implanted cardiac pacemakers or other electronic implants. 7.Patients with severe organic lesions of major organs such as the heart, liver, lungs and kidneys. 8.Patients with borderline thrombocytopenia; 9.Patients with hemodynamic instability; 10.Patients with leukemia.

Design outcomes

Primary

MeasureTime frame
Improvement in scarring assessed by ECCA one month after completion of three treatment sessions;

Secondary

MeasureTime frame
Improvement in scar appearance at months 0, 2, and 4;

Countries

China

Contacts

Public ContactYou Yi

The First Affiliated Hospital of Army Medical University

6378195@QQ.com+86 23 6876 6334

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026